|
HS Code |
607738 |
| Compound Name | D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt |
| Cas Number | 87366-50-1 |
| Molecular Formula | C10H16BrNO4S |
| Molecular Weight | 326.21 |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Optical Activity | D-form (levorotatory) |
| Melting Point | 195-200°C (decomposes) |
| Storage Temperature | 2-8°C |
| Purity | ≥98% |
As an accredited D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 25g amber glass bottle with a screw cap, labeled with product details, safety, and handling instructions. |
| Shipping | D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt is shipped in tightly sealed containers to prevent moisture and contamination. The chemical is handled with appropriate labeling and safety documentation, complying with relevant regulatory guidelines for transport. It is generally shipped at ambient temperature unless otherwise specified, and is protected from physical damage and incompatible substances. |
| Storage | D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt should be stored in a tightly sealed container, in a cool, dry, well-ventilated area, away from moisture, heat, and direct sunlight. Keep it away from incompatible substances such as strong oxidizers or bases. Store at room temperature and ensure proper labeling. Handle using appropriate personal protective equipment (PPE) to avoid chemical exposure. |
Applications of D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt in Industrial ManufacturingD-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt is a specialty chiral resolving agent that serves key roles in complex organic synthesis and pharmaceutical intermediate processes. As a direct producer with experience in downstream integrations, we provide this material to high-value sectors where strict regulatory oversight, dependable batch quality, and defined process utility are crucial to end-use performance. Below, we outline the principal industrial application scenarios based on the most relevant sectors actively using this compound. 1. Chiral Resolution for Active Pharmaceutical Ingredient (API) SynthesisPharmaceutical manufacturers employ this compound as a resolving agent for the preparation of optically pure amines and alcohols used in targeted small-molecule APIs. The stereoselective crystallization enabled by D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt underpins enantiomeric purity in high-potency drug substances. Formulators select this salt during the salt-formation stage to achieve separated enantiomeric intermediates, directly influencing API qualification outcomes and regulatory submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Enantioselective Synthesis in Fine Chemical ManufacturingManufacturers specializing in advanced intermediates for flavors, fragrances, and specialty reagents use D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt for selective kinetic resolution of secondary alcohols and related substrates. The controlled introduction of this agent during chiral alcohol or amine conversion processes enhances optical yields and supports reliable scale-up under cGMP or dedicated fine chemical guidelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Analytical Laboratory Standardization (Chiral HPLC Reference)Analytical reference laboratories integrate D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt as a chiral selector or resolving agent in the preparation of calibration standards for chiral HPLC method deployment. Its defined stereochemistry and purity support routine validation of enantiomeric quantification techniques across pharmaceutical and research contract labs, providing comparative reference points for process and release testing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research-Grade Optical Resolution in Academic and Biotech DevelopmentBiotechnology research institutes and university labs leverage the high reactivity of D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt in protocol development for novel chiral compound synthesis and proof-of-concept enantioseparation. The compound serves as a reproducible resolving agent, supporting advanced investigation into asymmetric catalysis, new chemical entity discovery, and teaching laboratory practicals focusing on stereoselective synthesis. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive D-3-Bromocamphor-8-Sulfonic Acid Ammonium Salt prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
D-3-Bromocamphor-8-sulfonic acid ammonium salt does not show up in everyday life, but in specialized chemical work this compound takes center stage. It stands out as an essential building block in creating advanced molecules used across pharmaceuticals and fine chemical synthesis. Our own experience running batches over many years has shown why it gets particular attention from research teams and manufacturers with demanding standards. This compound carries unique chiral properties, and those are not just academic details – they shape real-world results in enantioselective synthesis.
Every chemist can find a data sheet somewhere, but no single-page document tells the full story of this salt. D-3-Bromocamphor-8-sulfonic acid ammonium salt goes by more than one name in formal literature; what always matters to us is its enantiomeric purity. Getting consistent batches, each batch showing verified optical rotation, helps synthetic chemists who build new chiral molecules without unexpected byproducts. We produce this compound to support both pilot-scale and commercial development, and our real expertise shows in our ability to reach high purity levels—measured by HPLC and other recognized methods—and batch reproducibility over long campaigns. The material comes as a white to off-white crystalline powder, and every shipment undergoes careful in-lab checks for known impurities and absolute configuration.
We do not ship without confirming physical characteristics such as appearance, melting point, and solubility. Some manufacturers still view melting point as an afterthought, but in our plant the technicians check each lot for a narrow melting range. Any deviation gets pulled aside for further testing instead of landing in a customer’s flask. Moisture content also enters our audit process since the presence of water can cause unwanted reactivity for sensitive reactions. The salt’s shelf-life and storage guidelines draw from both textbook knowledge and real storage tests under different conditions—data that let our users minimize spoilage and avoid uncertainty in their workflow.
Ten years ago, a product like this served mainly as a research curiosity. That changed as pharmaceutical and agrochemical manufacturers realized how powerfully chiral auxiliaries can influence the outcome of asymmetric synthesis. The D-3-bromo configuration, paired with the sulfonic acid group, brings strong hydrophilicity. Ammonium salt form increases water solubility, a key point for anyone developing reactions that need clean separation between organic and aqueous phases. Our batches must never bring excess ammonium contamination, since that would alter downstream stoichiometry.
Our customers most often work with D-3-Bromocamphor-8-sulfonic acid ammonium salt as a resolving agent. Its stereoselectivity opens doors for separating racemic mixtures—especially those involving alcohols, amines, and acids where small details in molecular shape make all the difference. We know, from direct focus on process chemistry, that differences in enantioselectivity can cause yield swings of more than 5% on the same process just depending on minor fluctuations in purity or crystal morphology. So, we gear our manufacturing not only towards meeting a number in a certificate but achieving consistency that shows up in our client’s own analytical tests.
Outside resolution, our customers have explored these salts in catalyst development for stereoselective reactions. The bromo substituent gives unique electronic influence, and we work with academic groups optimizing C–H activation and oxidative coupling using our material. The feedback loop between lab bench and pilot vessel keeps us up-to-date on the changing demands for this class of auxiliary compounds.
Producing D-3-Bromocamphor-8-sulfonic acid ammonium salt is not a matter of mixing and packing. The base camphor backbone itself demands precision in handling hazardous reagents. During bromination, proper temperature and time drive selectivity; it takes a balance of reaction conditions to ensure substitution at the 3-position, avoiding unwanted over-bromination. Our chemists rely not just on recipe steps, but on real diagnostics from IR, NMR, and HPLC to confirm identity and purity before moving ahead to the next stage.
Sulfonation introduces another layer of difficulty. Over-sulfonation introduces bis-sulfonic byproducts, so control of sulfonating agent equivalents and temperature is critical. The ammonium salt formation requires anhydrous conditions to avoid partial hydrolysis or ammonium salt dissociation. Too much moisture at any point in the process can reduce product quality, and a missed step during filtrations encourages mother liquor carryover, risking increased impurity levels. Our plant has learned that investing more time in intermediate purification makes downstream batch validation easier and reduces headache later.
Waste and effluent present practical headaches. We know every kilogram of product brings several liters of spent acids and organics. Our engineering team uses closed-loop recovery and secondary oxidation to buckle down on effluent COD. Much of chemical manufacturing focuses on what goes into the bottle; our best results come when we give equal attention to what leaves our drains. Regular environmental review prevents surprises at inspection and keeps credibility with our long-term clients who themselves report on sustainability metrics.
By tracking process parameters for every batch and logging deviations, we reduce batch failures and root out issues before reaching scale-up. Partition coefficients, pH drift, equipment surface material—all make a difference. Plant operators flag even small departures from established norms, which helps us refine SOPs continuously.
D-3-Bromocamphor-8-sulfonic acid ammonium salt often gets compared with similar camphor sulfonic salts on the market, including the L- and D-enantiomers and their sodium, potassium, or other aliphatic salt forms. Having tried several of these ourselves, we can speak to the real differences they deliver in practice.
For starters, D-3-Bromo stands apart from the more common D- or L-camphor-10-sulfonic acid salts. Thanks to the bromine on the 3-position and the sulfonic acid on the 8-position, this salt confers altered steric and electronic effects in chiral recognition. In actual resolving agent experiments, we have seen sharper enantiomer separation using D-3-Bromo versus camphor-10-sulfonic acid. This creates cleaner isolation, especially for certain basic compounds, and reduces the need for repeated crystallization cycles. That practical edge stacks up quickly in a busy lab.
Switching from sodium or potassium salts to ammonium salt brings changes in workup. We have noticed ammonium salt forms dissolve more readily in water, especially at neutral to weakly acid pH, which translates to easier process handling during extraction and phase separation. Ammonium does not interfere as much as metal cations in many sensitive reactions, making this version the logical choice where downstream metal precipitation must be avoided.
Some competing resolving agents offer broad compatibility, but D-3-Bromocamphor-8-sulfonic acid ammonium salt stands out for its ability to separate tough cases in amine and amino alcohol resolutions. Through in-house experiments, our chemists isolated challenging beta-amino ester libraries with higher overall yields and enantiomer ratios than control runs using generic camphorsulfonic salts.
Quality assurance for a compound like this cannot stop at paper checks. We commit lab resources to ongoing stability and impurity testing—no batch leaves our site without orthogonal confirmation (HPLC, NMR, and, for some end-uses, chiral GC or SFC). The optical activity is not a formality, since minor racemization undermines every downstream operation. Our process team reviews spectral data, not just automated readouts. If a spectrum shows an unidentified shoulder, we dig deeper before release.
For clients scaling up new syntheses, we provide full supporting documentation including chromatographic traces and spectral overlays, not just summary numbers. Custom specification protocols are available after joint troubleshooting, when a customer needs to push reaction output or achieve regulatory compliance. Our experience shows that open lab communication avoids costly surprises at the regulatory review stage.
We have followed our materials from kilo-lab to pilot plant, and sometimes all the way into clinical API preparation. One recent collaboration with a pharmaceutical process team showed the value in sourcing the salt directly from a trusted manufacturing partner. They worked with us on batch-to-batch traceability—this was essential when their main synthetic step demonstrated enantiomeric excess near the edge of specification. Instead of only shipping lots, we worked with their analytical team to set up direct-to-chiral column methods on their own equipment for co-validation.
In specialty chemicals and flavors markets, our salt finds new utility again. The chiral backbone imparts the right level of differentiation for isomeric purification in fragrance intermediates, showing that its value ranges past strict pharmaceutical controls. The rapid solubility of the ammonium form lets technologists flush and rinse with less downtime for equipment cleaning between runs.
We have also supported academic clients optimizing transition-metal catalysis, where selectivity and purity make or break their results for publication and intellectual property filings. Their feedback feeds directly into our quality benchmarks and gives us early signals if new trends in usage are on the horizon.
Every facility that scales up production faces challenges neither research groups nor traders always see. One bottleneck involves the control of bromination. Starting with sub-standard camphor or incomplete bromination throws off not only analytical purity but raises the cost of reprocessing. Our solution includes securing upstream material of established quality and maintaining on-site capability for key transformation steps.
Another pain point emerges during sulfonation, where even minor temperature excursions affect product profile. Unscheduled downtimes or last-minute repair schedules sometimes push batch results outside the optimal range, so we rely heavily on continuous monitoring and proactive maintenance.
Keeping impurities controlled at low ppm levels requires repeat investment in analytical resources. Chiral contamination, trace metals, and undissolved solids all play roles in real-world manufacturing delays, not just theoretical risk profiles. Our investment in live-batch monitoring was driven not by industry checklists but by our own past frustration with needing to rework off-spec material. Over several years, this culture of vigilant monitoring changed our average product turnaround times and shipment reliability.
Demand surges, like those seen after a regulatory approval or new patent, put a strain on both raw material supply and qualified personnel. Our answer draws from cross-training operators and holding longer-term contracts for essential starting materials, ensuring we do not become a bottleneck downstream.
Each year, standards in process chemistry evolve. The requirements for chiral compound origin and traceability become stricter, especially as pharmaceutical and agrochemical applications receive greater oversight. We learned, sometimes the hard way, that meeting these new standards calls for robust documentation and rapid, open collaboration between process development, production, and analytical science.
Rather than relying solely on traditional batch release, we now pilot in-process controls paired with digitized record keeping, which shrinks response time for deviations. Clients looking for full transparency into their supply need rich data support, and that means not just analytical certificates but also supply chain details, batch genealogy, and deviation reporting.
Sustainability and safety expectations weigh heavily in chemical manufacturing. We have made direct investments in vapor recovery, waste minimization, and in continual operator training for hazardous material handling. Switching certain filtration systems to closed systems lowered direct emissions and improved operator safety. Active engagement in environmental reporting helped us anticipate changes in regulations rather than merely reacting.
As more research teams and production groups advance the chemistry of stereoselectivity, the demand for specialized resolving agents will likely rise. Our direct experience with D-3-Bromocamphor-8-sulfonic acid ammonium salt proves that staying close to the synthesis, not just relying on the paperwork, delivers real results. Having a supplier that actually understands what goes into producing and quality-checking this material—because we make it, not just sell it—matters at every scale from bench to commercial supply. Those who work in chemical development know the importance of reliability and adaptability. We see every run as another opportunity to refine both our products and our processes, with the cumulative results showing up in our customers’ finished products and the chemical literature itself.